HOME >> BIOLOGY >> NEWS
Clemson researcher receives Komen grant

CLEMSON A Clemson University scientist has received $250,000 to pursue a promising line of research for a way to treat breast cancer. Wen Y. Chen, associate professor in Clemson's department of biological sciences and assistant director of the Oncology Research Institute of Greenville Hospital System, has received funding from the prestigious Susan G. Komen Breast Cancer Foundation in Dallas. He is the first scientist from South Carolina to receive a Komen Foundation grant. Chen will use the money to further his research on stopping breast cancer cells from developing.

"We are excited and grateful for this grant," said Chen. "It signals that we are on the right track. In the past five years, we have focused on developing a potential treatment for breast cancer. With this grant we can move ahead on testing whether the combination approach will significantly improve the existing treatment in an aggressive subtype of breast cancer."

Scientists have learned that human prolactin (PRL), a hormone normally produced in the brain and mainly responsible for mammary gland development and milk production, may be involved in breast cancer development.

"The involvement of PRL in breast cancer is likely due to, in some cases, the fact that mutated breast cells produce PRL as their own survival-growth factor, which keeps most growth signal at "on" position," said Chen. "This self-sustained, vicious growth ability eventually leads to cancer formation."

To "turn off" these growth signals induced by PRL, scientists set out to develop a counteragent -- an antagonist. Working with his colleagues and graduate students at the Oncology Research Institute, Chen has demonstrated that a mutated PRL, called PRL antagonist (G129R), is able to bind specifically to breast cancer cells and block the effect of PRL, inhibiting tumor growth in mice. What's more, the PRL antagonist has synergistic effects with the breast cancer drug Herceptin, which has only 30 percent response
'"/>

Contact: Wen Y. Chen
wenc@clemson.edu
864-455-1457
Clemson University
28-May-2004


Page: 1 2

Related biology news :

1. Clemson University spin-off uses corn to make plastics, provide cleaner air
2. Clemson researcher places hope on pushy photons
3. Clemson University researcher reaches for the stars to prevent osteoporosis
4. Clemson launches S.C. DNA Learning Center
5. Clemson dedicates biotech research complex
6. Breakthrough Clemson research appears in Science
7. Clemson researcher takes part in breakthrough research on insects
8. Clemson researchers find bacteria fighter that does not promote bacterial resistance
9. Clemson researchers identify mental retardation gene
10. Clemson researchers create biosensors to protect nations food and water supplies
11. Clemson-led team makes breakthrough in controlling Bt resistance in pests

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/11/2018)... ... October 10, 2018 , ... For the first ... patients to learn about their treatment options. The unique patient education tool seeks ... cancer (TNBC), and was developed through a collaboration between the Centers for ...
(Date:10/5/2018)... ... October 05, 2018 , ... The ... is announcing a 10% price increase across all markets in January 2019. ... the building blocks of protein — for the parenteral nutrition, biopharmaceutical, infant/medical food, ...
(Date:10/5/2018)... LINDA, Calif. (PRWEB) , ... October 04, 2018 , ... ... results of some of the tests such as cardiac troponin has serious clinical complications. ... population, although the exact prevalence is still unknown. , High dose of biotin ...
Breaking Biology News(10 mins):
(Date:10/5/2018)... ... 04, 2018 , ... Power T Handle, LLC, a surgeon-driven, ... Orthopedics This Week during the 2018 National Association of Spine Surgeons (NASS) meeting ... instrument that delivers operating room efficiencies through increased speed and reduced surgeon fatigue ...
(Date:10/2/2018)... BASEL, Switzerland (PRWEB) , ... ... ... leading provider of advanced software solutions for biopharmaceutical R&D, today announced a ... ambr® mini-bioreactor systems from Sartorius, a leading international pharmaceutical and laboratory equipment ...
(Date:9/28/2018)... ... 2018 , ... GlycoMark®, Inc. has announced a partnership with ... the only FDA-cleared blood test specific to detecting recent hyperglycemia and hyperglycemic excursions ... GlycoMark test to its network of physicians through its sales organization and MD ...
(Date:9/27/2018)... ... September 26, 2018 , ... Nvision Biomedical ... Pedicle Screw System today at the North American Spine Society (NASS) Annual Meeting, ... Nvision focus Pedicle Screw System, which received clearance from the U.S. Food and ...
Breaking Biology Technology:
Cached News: